| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.5 | 0.08 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |